0001572426-15-000062.txt : 20150520
0001572426-15-000062.hdr.sgml : 20150520
20150520204640
ACCESSION NUMBER: 0001572426-15-000062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150518
FILED AS OF DATE: 20150520
DATE AS OF CHANGE: 20150520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lismore Damian T.
CENTRAL INDEX KEY: 0001560864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15881072
MAIL ADDRESS:
STREET 1: 12270 WILKINS AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20852
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-05-18
0001618561
Nexvet Biopharma plc
NVET
0001560864
Lismore Damian T.
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE, MOUNT MERRION
BLACKROCK
L2
IRELAND
0
1
0
0
Chief Financial Officer
Option to Purchase Shares
15.00
2015-05-18
4
A
0
100000
0
A
2020-05-18
Ordinary Shares
100000
100000
D
The Option shall vest with respect to 25,000 shares on 5/18/15 and with respect to 5,000 shares on each of 6/30/15, 9/30/15, 12/31/15, 3/31/16, 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17, 3/31/18, 6/30/18, 9/30/18 and 12/31/18.
/s/ Damian Lismore by Geraldine T. Farrell, Attorney-in-Fact
2015-05-20